Save your seat

Speaker detail

  • Daniel Naranjo
  • Associate Medical Director
  • Takeda

Dr Daniel Naranjo is Global Safety Lead- Oncology at Takeda Oncology. Prior to working at Takeda, Daniel has led the implementation and integration of complex global pharmacovigilance operations with medical device safety for combination products for dialysis patients. He has also led successful work streams focused on FDA warning letter remediation associated with combination product safety. Daniel is a physician, who completed his pre-doctoral work in Neuro-critical care at the University of Maryland and in Traum at the University of Miami along with post-doctoral work in South Miami at Larkin Community Hospital.